Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -83.027% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: Cc1ccc(N/C(N)=N/c2nc(C)cc(N3CCCCC3)n2)c(C)c1
b: N#CC(C#N)C(c1ccsc1)c1c(-c2ccccc2)[nH][nH]c1=O
c: CCN(C(=O)Cn1nc(C(=O)O)c2ccccc2c1=O)C1CCCCC1
d: O=C1CNCc2[nH]c3ccccc3c2N1c1ccccc1
e: CCOC(=O)C1=C(CN2CCN(C(=O)c3ccco3)CC2)NC(=O)NC1c1ccc(OC)cc1
Answer: a. Cc1ccc(N/C(N)=N/c2nc(C)cc(N3CCCCC3)n2)c(C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N/C(N)=N/c2nc(C)cc(N3CCCCC3)n2)c(C)c1
Cc1ccc(N/C(N)=N/c2nc(C)cc(N3CCCCC3)n2)c(C)c1
1-(2,4-dimethylphenyl)-2-(4-methyl-6-piperidin-1-ylpyrimidin-2-yl)guanidine